Decreased levels of vitamin D in Post-Corona Virus-19 Disease syndrome (PCS) patients compared to a control group.

Publication date: Feb 01, 2025

Vitamin D deficiency is defined by most experts as a level of less than 20 ng/ml. Studies have shown a relationship between musculoskeletal pain, muscle weakness, headache, and fatigue with low vitamin D level. The term Post-Corona Virus-19 Disease syndrome (PCS) describes new, returning or ongoing symptoms more than 12 weeks after Corona Virus Disease -19 (COVID-19) infection which cannot be explained by any other disorders or illnesses. The most prominent symptoms in PCS are fatigue, headache, and attention disorders. These similarities in PCS and vitamin D deficiency leads to the hypothesis of an association. The aim of this study was to find possible differences in vitamin D levels between PCS patients and a control group without PCS. We measured vitamin D levels from April 2021 to December 2022 in 75 (2021) and 73 (2022) subjects (PCS) and compared these values with data from 2019 to 2022 in a non-PCS control group (non-PCS). We found significantly lower (p

Concepts Keywords
December Adult
Headache Aged
Therapy Case-Control Studies
Vitamin COVID-19
Female
Humans
Male
Middle Aged
Post-Acute COVID-19 Syndrome
Post-COVID-syndrome
SARS-CoV-2
Vitamin D
Vitamin D
Vitamin D Deficiency
Vitamin D deficiency

Semantics

Type Source Name
drug DRUGBANK Vitamin D
disease MESH syndrome
disease MESH Vitamin D deficiency
disease MESH musculoskeletal pain
disease MESH Virus Disease
disease MESH COVID-19
disease MESH infection
disease MESH Post-Acute COVID-19 Syndrome

Original Article

(Visited 4 times, 1 visits today)